Acute coronary syndrome (heart attack) is a leading cause of death worldwide, but 30% patients die before getting to a hospital. Our drug-device combo, in partnership with a pharmaceutical company, makes it possible for patients to receive diagnosis and treatment at home, in less than 10 min. This is a paradigm shift in the care of heart attack that can save time, money and many lives.
We learned a lot of the processes in commercializing a new medical product. We also made many connections to potential customers and strategic partners.
"The MedTech Accelerator accelerates product development and market adoption. It is highly recommended."
Ruey-Kang Chang, MD
CEO, QT Medical